pharmaceutical ingredients Fundamentals Explained
“The current situation has exposed some structural weaknesses within the EU’s medicines source chain as well as a high dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides explained. She advisable that supply chain problems be dealt with in an EU pharmaceutical strategy expected to become launched by the top with th